CRISPR 和 CAS 基因市場規模、佔有率、成長分析、按產品、按服務、按應用、按最終用戶、按地區 - 行業預測，2025-2032 年

2023年CRISPR和CAS基因市場規模為35億美元，從2024年的47.8億美元成長到2032年的583.3億美元，複合年成長率預計將成長36.70%。

近年來，在不同領域對基因編輯工具和治療方法的需求不斷成長的推動下，CRISPR 和 CAS 基因市場經歷了顯著的成長和演變。我們的綜合報告包括廣泛的價值鏈分析，以幫助製造商在這個不斷擴大的市場中獲得競爭優勢。主要驅動力包括擴大醫療保健、農業和工業生物技術應用範圍的技術進步。 CRISPR（成簇規則間隔短回文重複）和 Cas（CRISPR 相關）技術正在徹底改變基因工程並提高 DNA 修飾的精確度。儘管存在倫理和監管方面的挑戰，但遺傳疾病的擴散、正在進行的研究和研究合作正在進一步加速成長。隨著技術的進步和我們對基因功能的了解加深，CRISPR 和 CAS 市場有望改變多個行業。

目錄

介紹

• 研究目的
• 調查範圍
• 定義

調查方法

• 資訊採購
• 二手資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制因素和挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 價格分析
• 監管環境
• 案例研究
• 技術進步

CRISPR 和 CAS 基因市場規模：依產品

• 市場概況
• 試劑套件和試劑
  • Cas蛋白和酶
  • 引導RNA
  • 其他
• 圖書館
• 設計工具
• 抗體
• 其他

CRISPR 和 CAS 基因市場規模：按服務分類

• 市場概況
• 細胞株工程
• GRNA設計與合成
• 篩檢服務
• 其他

CRISPR 和 CAS 基因市場規模：按應用分類

• 市場概況
• 生物醫學
  • 基因組工程
  • 疾病模型研究
  • 功能基因體學
  • 表觀遺傳學
  • 其他
• 農業

CRISPR 和 CAS 基因市場規模：按最終用戶分類

• 市場概況
• 生物技術和製藥公司
• 學術和政府研究機構
• 合約研究組織（CROS）
• 其他

CRISPR和CAS基因市場規模

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東/非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲

競爭資訊

• 前5名企業對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分類的佔有率分析
  • 收益與前一年同期比較（2022-2024）

主要企業簡介

• CRISPR Therapeutics（Switzerland）
• Beam Therapeutics（USA）
• Intellia Therapeutics（USA）
• Editas Medicine（USA）
• Caribou Biosciences（USA）
• Verve Therapeutics（USA）
• Prime Medicine（USA）
• Sangamo Therapeutics（USA）
• Wave Life Sciences（Singapore）
• Metagenomi（USA）
• Mammoth Biosciences（USA）
• Synthego Corporation（USA）
• EGenesis（USA）
• Inscripta（USA）
• Cellectis（France）
• OriGene Technologies（USA）
• Precision BioSciences（USA）
• Recombinetics（USA）

結論和建議

CRISPR and CAS Gene Market size was valued at USD 3.5 Billion in 2023 and is poised to grow from USD 4.78 Billion in 2024 to USD 58.33 Billion by 2032, growing at a CAGR of 36.70% during the forecast period (2025-2032).

The CRISPR and CAS gene market has undergone remarkable growth and evolution recently, fueled by rising demand for gene-editing tools and therapies across diverse sectors. Our comprehensive report includes an extensive value chain analysis, empowering manufacturers to secure a competitive advantage in this expanding market. Key drivers include technological advancements that broaden application scopes in healthcare, agriculture, and industrial biotechnology. The CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and Cas (CRISPR-associated) technologies have revolutionized genetic engineering, offering precision in DNA modification. The surge in genetic disorders, ongoing research, and collaboration further accelerate growth, despite ethical and regulatory challenges. As technology progresses and understanding of gene functions deepens, the CRISPR and CAS market is set to transform multiple industries.

Top-down and bottom-up approaches were used to estimate and validate the size of the CRISPR and CAS Gene market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

CRISPR and CAS Gene Market Segmental Analysis

Global CRISPR and CAS Gene Market is segmented by product, service, application, end user and region. Based on product, the market is segmented into kits & reagents, libraries, design tool, antibodies and others. Based on service, the market is segmented into cell line engineering, GRNA design & synthesis, screening services and others. Based on application, the market is segmented into biomedical and agricultural. Based on end user, the market is segmented into biotechnology & pharmaceutical companies, academic & government research institutes, contract research organizations (CROS) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the CRISPR and CAS Gene Market

The CRISPR and CAS Gene market is significantly driven by the rising prevalence of genetic disorders, which include various conditions stemming from mutations or changes in specific genes. As the understanding of these genetic conditions deepens, there is a growing demand for advanced and precise gene-editing technologies like Crispr and Cas. These innovative tools offer tremendous potential for creating targeted therapies and personalized treatment approaches for patients with genetic disorders. The increasing global incidence of genetic diseases, combined with the urgent need for effective treatment solutions, fuels the demand for Crispr and Cas technologies, thus accelerating market expansion.

Restraints in the CRISPR and CAS Gene Market

The CRISPR and CAS Gene market faces several restraints primarily stemming from regulatory and ethical challenges associated with gene editing technologies. While the transformative power of Crispr offers immense possibilities, it simultaneously raises significant concerns regarding its responsible and ethical application. Discussions around the implications of germline editing, potential off-target effects, and unforeseen consequences fuel ongoing debates within the scientific community and beyond. Moreover, the lack of uniform regulatory frameworks across various countries and regions creates inconsistencies that may hinder market growth and restrict the adoption of these innovative gene-editing solutions, thereby impacting their overall potential in various applications.

Market Trends of the CRISPR and CAS Gene Market

The CRISPR and Cas gene market is witnessing significant growth, particularly in the agricultural sector, driven by the increasing adoption of gene editing technologies to enhance crop traits and resilience. Farmers and breeders are leveraging CRISPR for precise modifications, enabling the development of genetically modified organisms (GMOs) that exhibit superior yield, disease resistance, and adaptive traits like drought tolerance. This trend is heavily influenced by the urgent need for sustainable agricultural practices, heightened by global food security challenges and a rising population. As stakeholders seek innovative solutions, the CRISPR market is poised for expansion, fostering advancements in crop productivity and sustainable farming practices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global CRISPR and CAS Gene Market Size by Product & CAGR (2025-2032)

• Market Overview
• Kits & Reagents
  • Cas Proteins & Enzymes
  • Guide RNA
  • Others
• Libraries
• Design Tool
• Antibodies
• Others

Global CRISPR and CAS Gene Market Size by Service & CAGR (2025-2032)

• Market Overview
• Cell Line Engineering
• GRNA Design & Synthesis
• Screening Services
• Others

Global CRISPR and CAS Gene Market Size by Application & CAGR (2025-2032)

• Market Overview
• Biomedical
  • Genome Engineering
  • Disease Model Studies
  • Functional Genomics
  • Epigenetics
  • Others
• Agricultural

Global CRISPR and CAS Gene Market Size by End User & CAGR (2025-2032)

• Market Overview
• Biotechnology & Pharmaceutical Companies
• Academic & Government Research Institutes
• Contract Research Organizations (CROS)
• Others

Global CRISPR and CAS Gene Market Size & CAGR (2025-2032)

• North America (Product, Service, Application, End User)
  • US
  • Canada
• Europe (Product, Service, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Service, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Service, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Service, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• CRISPR Therapeutics (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beam Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intellia Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Editas Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Caribou Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Verve Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prime Medicine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sangamo Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wave Life Sciences (Singapore)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Metagenomi (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mammoth Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Synthego Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EGenesis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Inscripta (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellectis (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OriGene Technologies (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Precision BioSciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Recombinetics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations